Clik here to view.
Pathway to Quality Cardiovascular Imaging Trials
Cardiovascular diseases are the leading cause of death in the world and as such, the cause, prevention and treatment of all cardiovascular disease remains a very active field in the research community....
View ArticleClik here to view.
Cardiovascular Imaging: Not Just for Cardiovascular Trials
Cardiovascular disease is the leading cause of death globally with approximately 17.3 million deaths annually. Underlying heart disease are numerous conditions such as atherosclerosis, myocardial...
View ArticleClik here to view.
8 Essential Imaging Strategies to Revolutionize Your Clinical Study
Imaging is utilized in clinical trials across most therapeutic areas and is leveraged to monitor safety, assess efficacy, and provide primary, secondary or exploratory endpoints. The challenge imaging...
View ArticleClik here to view.
How to Improve NASH Eligibility Screening and Gain Insight into the...
Co-authored by Gavin Nichols.Nonalcoholic steatohepatitis (NASH) development programs are shifting focus from targeting the clinical impacts of NASH on reversing the effects of fibrosis and cirrhosis,...
View ArticleClik here to view.
Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials –...
The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), both potentially progressive diseases that can lead to cirrhosis and liver cancer,1 is increasing.2...
View ArticleClik here to view.
Increasing Awareness of NAFLD/NASH – 2019 Is “the Year of NASH” According to...
Non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH), is estimated to become the most common chronic liver condition in Western populations. It has been...
View ArticleClik here to view.
Seeking Clarity in the Audit Approach
Many questions still remain several years after the July 2012 ODAC (Oncologic Drug Advisory Committee) Meeting on the "Evaluation of Radiologic Review of Progression-free Survival in Non-Hematologic...
View Article